Back to Results
First PageMeta Content
Pharmaceutical sciences / Clinical research / Pharmaceutical industry / Drug safety / Food and Drug Administration / Adverse effect / Pharmacovigilance / Adverse event / Medical device / Medicine / Health / Pharmacology


Guidance Document for Industry Reporting Adverse Reactions to Marketed Health Products* (Effective Date: [removed]Canada Vigilance Adverse Reaction Monitoring Program and Database, a program of MedEffect™
Add to Reading List

Document Date: 2013-06-24 11:49:36

Open Document

File Size: 275,84 KB

Share Result on Facebook

Company

V Working Group / AEs / /

Country

Canada / /

Event

FDA Phase / /

IndustryTerm

health product / drug-food interactions / biotechnology products / consumer products / health services / non-prescription pharmaceutical drugs / natural health product / health products / medicinal product / therapeutic product / fractionated blood products / administered health product / natural health products / pharmaceutical drugs / non-prescription pharmaceuticals / marketed health product / marketed health products / food / /

MedicalCondition

disease / disorder / /

MedicalTreatment

traditional medicine / /

Organization

World Health Organization / Council for International Organizations of Medical Sciences / Marketed Health Products Directorate / /

/

Position

Queen / Minister / Minister of Health / General / Reporter / /

Product

Shure E2c Headphone/Headset / compliance / /

ProgrammingLanguage

php / /

ProvinceOrState

Arkansas / /

PublishedMedium

Consumer Reports / /

Technology

biotechnology / radiopharmaceuticals / PDF / /

URL

www.hc-sc.gc.ca/dhp-mps/pubs/medeff/_guide/2011-guidance-directrice_reporting-notification/index-eng.php / /

SocialTag